A new paper in Molecular Biology and Evolution finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In effect, the more HIV in the blood, the easier it is for the virus ...
Jan 10, 2024
0
41
Increasing patients' out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP use and ...
Jan 8, 2024
0
2
The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies.
Jan 5, 2024
0
51
Over the last decade, several case studies have reported that people with multiple sclerosis (MS) who started antiretroviral therapy for HIV (to keep the virus in check) subsequently found that their MS symptoms had either ...
Dec 21, 2023
0
1
From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.
Dec 19, 2023
0
0
An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious ...
Dec 14, 2023
1
36
Following the announcement of the WHO call to eliminate cervical cancer as a public health problem in 2020, there has been encouraging global progress in implementing and expanding Human papillomavirus (HPV) immunization, ...
Dec 14, 2023
0
0
An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: A nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles ...
Dec 12, 2023
0
0
For neonates with in utero HIV-1, very early antiretroviral therapy (ART) can achieve sustained virological suppression, according to a study published online Dec. 4 in The Lancet HIV.
Dec 12, 2023
0
0
CBD may be a promising therapy for people living with HIV. While the virus can be controlled with treatment, it can still wreak havoc on the brain and cause problems with cognition.
Dec 11, 2023
0
41
